Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22522739 | 0.87 | PDK2 (0.48) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL23273209 | 0.84 | PDK2 (0.45) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL30803793 | 0.84 | PDK2 (0.45) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL4822724 | 0.84 | SLC6A3 (0.41) | PDK2SLC6A3HDAC8HDAC6GPR84 | |
| SCHEMBL25662283 | 0.81 | PDK2 (0.40) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL19001858 | 0.80 | PDK2 (0.45) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL15587219 | 0.80 | PDK2 (0.55) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL20199300 | 0.79 | PDK2 (0.46) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL20174708 | 0.79 | PDK2 (0.46) | PDK2CA1CA2CA9CA7 | |
| SCHEMBL25662244 | 0.79 | PDK2 (0.43) | PDK2CA1CA2CA9CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680059-B2 | Organic mixture and application thereof in organic electronic devices | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2023-06-20 | — | — | US | disclosed |
| US-11680059-B2 | Organic mixture and application thereof in organic electronic devices | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2023-06-20 | — | — | US | disclosed |
| EP-3464244-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-11-17 | — | — | EP | disclosed |
| US-20200317646-A1 | ORGANIC MIXTURE AND APPLICATION THEREOF IN ORGANIC ELECTRONIC DEVICES | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2020-10-08 | — | — | US | disclosed |
| WO-2017207596-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317646-A1 | ORGANIC MIXTURE AND APPLICATION THEREOF IN ORGANIC ELECTRONIC DEVICES | OCIAD1, OCIAD2, SORD | PDK2 558/4885CA1 4072/4885CA2 3010/4885 |
| US-11680059-B2 | Organic mixture and application thereof in organic electronic devices | OCIAD1, OCIAD2, SORD | PDK2 558/4885CA1 4072/4885CA2 3010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.